SENS vs. TRNS, ALNT, EYPT, LAB, CTKB, AEHR, QSI, QTRX, MASS, and FEIM
Should you be buying Senseonics stock or one of its competitors? The main competitors of Senseonics include Transcat (TRNS), Allient (ALNT), Eyepoint Pharmaceuticals (EYPT), Standard BioTools (LAB), Cytek Biosciences (CTKB), Aehr Test Systems (AEHR), Quantum-Si (QSI), Quanterix (QTRX), 908 Devices (MASS), and Frequency Electronics (FEIM). These companies are all part of the "measuring and control equipment" industry.
Senseonics vs. Its Competitors
Transcat (NASDAQ:TRNS) and Senseonics (NYSE:SENS) are both small-cap measuring and control equipment companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, profitability, analyst recommendations, risk and valuation.
98.3% of Transcat shares are owned by institutional investors. Comparatively, 12.4% of Senseonics shares are owned by institutional investors. 2.3% of Transcat shares are owned by insiders. Comparatively, 4.3% of Senseonics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
In the previous week, Transcat had 8 more articles in the media than Senseonics. MarketBeat recorded 8 mentions for Transcat and 0 mentions for Senseonics. Transcat's average media sentiment score of 0.62 beat Senseonics' score of 0.00 indicating that Transcat is being referred to more favorably in the media.
Transcat currently has a consensus price target of $114.00, indicating a potential upside of 28.31%. Senseonics has a consensus price target of $1.55, indicating a potential upside of 216.33%. Given Senseonics' stronger consensus rating and higher probable upside, analysts clearly believe Senseonics is more favorable than Transcat.
Transcat has higher revenue and earnings than Senseonics. Senseonics is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.
Transcat has a beta of 0.73, suggesting that its share price is 27% less volatile than the S&P 500. Comparatively, Senseonics has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500.
Transcat has a net margin of 5.21% compared to Senseonics' net margin of -362.30%. Transcat's return on equity of 6.47% beat Senseonics' return on equity.
Summary
Transcat beats Senseonics on 11 of the 17 factors compared between the two stocks.
Get Senseonics News Delivered to You Automatically
Sign up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SENS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Senseonics Competitors List
Related Companies and Tools
This page (NYSE:SENS) was last updated on 7/3/2025 by MarketBeat.com Staff